Clinical Trials

200 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05941520 2026-03-18

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

80 enrolled

Phase 3 Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02954874 2026-03-17

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

1,155 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02515110 2026-03-13

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

137 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase 2/3 Suspended

928 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06671912 2026-03-04

LoTam

Phase 3 Suspended

1,156 enrolled

Phase 2 Not yet recruiting

Breast Carcinoma In Situ

NCT07443943 2026-03-02

AIMSS-RPS

20 enrolled

Breast Carcinoma In Situ

NCT05898789 2026-02-25

Virtual Rehabilitation for Cancer Survivors

BreastGastrointestinalHead & NeckLymphoid

388 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Lymphoproliferative Disorders, Colorectal Neoplasms

NCT04906200 2026-02-19

YES

400 enrolled

Phase 1 Not yet recruiting

Breast Carcinoma In Situ

NCT07408856 2026-02-13

CAN1012 in OED, DCIS, and LCIS.

60 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT03766009 2026-02-11

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

627 enrolled 9 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT04368702 2026-02-09

CONFIRM

BreastGastrointestinalGenitourinaryHead & NeckLymphoid

70 enrolled

Breast Carcinoma In Situ, Urinary Bladder Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, Lymphoma, Stomach Neoplasms, Lymphoma, Mantle-Cell

NCT07042581 2026-02-06

A Study of Revaree Plus in People With Breast Cancer

Phase 4 Recruiting

60 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT04054557 2026-02-05

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

Phase NA Completed

305 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT06115486 2026-02-04

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

30 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma in Situ, Hypertrophy, Motor Activity, Neoplasms

NCT04570956 2026-01-23

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Phase 2 Terminated

65 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

80 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT04871516 2026-01-22

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

103 enrolled

Breast Carcinoma In Situ

NCT04754412 2026-01-20

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

256 enrolled

Breast Carcinoma In Situ

NCT03345420 2025-12-30

NOVEMBER

Phase 2 Completed

102 enrolled 12 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06297265 2025-12-18

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

50 enrolled

Phase 2 Active not recruiting

Breast Carcinoma In Situ

NCT01245712 2025-12-17

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

200 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06008158 2025-12-10

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Phase 2 Suspended

48 enrolled

Breast Carcinoma In Situ

NCT06153836 2025-12-04

Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction

20 enrolled

Phase 2 Enrolling by invitation

Breast Carcinoma In Situ

NCT06843681 2025-11-28

Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

54 enrolled

Breast Carcinoma In Situ

NCT03979508 2025-11-12

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Phase 2 Terminated

26 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Fibrocystic Breast Disease, Triple Negative Breast Neoplasms

NCT04496739 2025-09-17

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

412 enrolled

Breast Carcinoma In Situ

NCT06275126 2025-09-09

CONSYDER

800 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT06538389 2025-08-29

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

36 enrolled

Phase 1 Active not recruiting

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT03317405 2025-08-28

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

32 enrolled 12 charts

Phase 2 Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06033092 2025-08-28

TOLERANT

200 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Phase 2/3 Completed

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT07044310 2025-07-29

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

38 enrolled

Breast Carcinoma In Situ

NCT04290897 2025-07-15

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors

Phase 2 Completed

18 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT04993313 2025-06-12

Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study

62 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT01819233 2025-06-06

CAREFOR

Phase NA Completed

38 enrolled 10 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT05086705 2025-04-22

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Phase NA Completed

50 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hot Flashes

NCT06931548 2025-04-17

Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery

100 enrolled

Phase 3 Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms

NCT01905046 2025-04-13

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

86 enrolled 10 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT04549571 2025-04-02

SHARES

543 enrolled